For T2DM-related NAFLD, quercetin regulates cholesterol homeostasis and converts cholesterol into bile acids (BAs) by downregulating the mTOR/YY1 signaling pathway, exerting hepatoprotective effects [33]. The gene discussed is MTOR; the disease is metabolic dysfunction-associated steatotic liver disease.